Windward Bio Group Debuts on Nasdaq: 68% Surge, $1.69B Market Cap & Sanofi Investment Fuel Biotech Growth
Windward Bio Group AG’s Nasdaq debut jumps 68%, raising $225 m and reaching a $1.7 billion market cap, backed by Sanofi and targeting asthma, COPD, and dermatitis with licensed Chinese assets.
3 minutes to read
